← FDA Drug Approvals (Drugs@FDA)

EMRELIS

BLA · Biologics License Application · Sponsor: ABBVIE INC · Approved 2025-05-14

Drug application

FDA Application #

BLA761384

Application type

Biologics License Application

Brand name

EMRELIS

Generic name

TELISOTUZUMAB VEDOTIN

Active ingredients

TELISOTUZUMAB VEDOTIN-TLLV

Dosage form

VIAL

Route

SINGLE-DOSE

Marketing status

Prescription

Sponsor

ABBVIE INC

Manufacturer

AbbVie Inc.

First approval

2025-05-14

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown